Name: 4th Annual Non-alcoholic Steatohepatitis (NASH) Summit
Start: 2020-12-15
End: 2020-12-18
Location: Boston Park Plaza

OVERVIEW

4th Annual Non-alcoholic Steatohepatitis (NASH) Summit is organized by Hanson Wade. The session is held from Dec 15 - 18, 2020 at Boston Park Plaza, Boston, Massachusetts, United States of America.

Description:
Now in its 4th year, the NASH Summit (Boston, MA) is the industry’s most comprehensive conference for advancing the development of successful NASH candidates.

By providing an unrivaled breadth of thought-leading discussion across discovery, translational, non-invasive biomarker and clinical drug development tracks, as well as new content on clinical safety, pathological fibrosis and market access; this intimately focused discussion and networking forum has the complete agenda you need to navigate the next 12 months of NASH drug development.

Join conference Chair Jason Campagna, Senior Vice President & Global NASH Lead at Intercept and 80 other topic leaders as they address the challenges and consequences of change in the NASH market.

• Critically evaluate and return on successes and setbacks to date to learn from lessons and devise a plan of action to optimize candidate success
• Collaboratively evaluate the novel, innovative preclinical modalities that more robustly recapitulate fibrogenesis to more confidently translate anti-fibrotic efficacy into the clinic
• Check the latest scientific insights into hepatocyte differentiation and its impact on immune cells, ductular reaction and fibrosis to better inform target identification
• Recognize the clinical utility of non-invasive diagnostics in the normal algorithm of care and review the payer’s thoughts on the need to biopsy
• Overcome disconnect between NASH reduction in phase 2 and NASH resolution in phase 3 as well as rationalize a systemic approach addressing NASH in combination, as a manifestation of wider metabolic dysfunction

Additional details will be posted as soon as information is available.